1. Therapeutic Opportunities for Muscarinic Receptors in the Central Nervous System
2. Lipophilic muscarinic M2 antagonists as potential drugs for cognitive disorders
3. Asberom, T.; Billard, B.; Binch, H.; Clader, J. W.; Cox, K.; Crosby, G.; Duffy, R. A.; Ford, J.; Greenlee, W.; Guzik, H.; Kozlowski, J. A.; Lachowicz, J. E.; Li, S.; Liu, C.; Lowe, D.; McCombie, S.; Ruperto, V. B.; Strader, C.; Tayler, L. A.; Vice, S.; Zhao, H.; Zhou, G. 221nd ACS National Meeting, San Diego, CA, April 1–5, 2001.